SI1075477T1 - Novi benzonaftiridin-N-oksidi - Google Patents

Novi benzonaftiridin-N-oksidi

Info

Publication number
SI1075477T1
SI1075477T1 SI9930279T SI9930279T SI1075477T1 SI 1075477 T1 SI1075477 T1 SI 1075477T1 SI 9930279 T SI9930279 T SI 9930279T SI 9930279 T SI9930279 T SI 9930279T SI 1075477 T1 SI1075477 T1 SI 1075477T1
Authority
SI
Slovenia
Prior art keywords
oxides
hand
benzonaphthyridine
novel
novel benzonaphthyridine
Prior art date
Application number
SI9930279T
Other languages
English (en)
Inventor
Beate Gutterer
Hermann Amschler
Wolf-R�diger ULRICH
Thomas Martin
Thomas Br
Armin Hatzelmann
Hildegard Boss
Rolf Beume
Daniela Bundschuh
Hans-Peter Kley
Dieter Flockerzi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1075477T1 publication Critical patent/SI1075477T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
SI9930279T 1998-05-05 1999-04-27 Novi benzonaftiridin-N-oksidi SI1075477T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98108124 1998-05-05
PCT/EP1999/002827 WO1999057118A1 (de) 1998-05-05 1999-04-27 Neue n-oxide
EP99922133A EP1075477B1 (de) 1998-05-05 1999-04-27 Neue Benzonaphtyridin-N-oxide

Publications (1)

Publication Number Publication Date
SI1075477T1 true SI1075477T1 (sl) 2003-08-31

Family

ID=8231880

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930279T SI1075477T1 (sl) 1998-05-05 1999-04-27 Novi benzonaftiridin-N-oksidi

Country Status (12)

Country Link
US (1) US6306869B1 (sl)
EP (1) EP1075477B1 (sl)
JP (1) JP2002513793A (sl)
AT (1) ATE234301T1 (sl)
AU (1) AU3928999A (sl)
CA (1) CA2330738A1 (sl)
DE (1) DE59904535D1 (sl)
DK (1) DK1075477T3 (sl)
ES (1) ES2195571T3 (sl)
PT (1) PT1075477E (sl)
SI (1) SI1075477T1 (sl)
WO (1) WO1999057118A1 (sl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224745T3 (es) 1998-08-31 2005-03-01 Altana Pharma Ag N-oxidos de benzonaftiridina con actividad inhibidora de pde3 y pde4.
KR100701904B1 (ko) * 1999-08-21 2007-04-02 알타나 파마 아게 Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
ATE394378T1 (de) 2000-01-11 2008-05-15 Nycomed Gmbh Phenanthridin -n- oxide
PT1377574E (pt) * 2001-02-21 2005-05-31 Byk Gulden Lomberg Chem Fab 6-fenilbenzonaftiridinas
US20060113968A1 (en) * 2002-08-17 2006-06-01 Altana Pharma Ag Novel benzonaphthyridines
EP1539164B1 (en) 2002-08-29 2006-12-20 ALTANA Pharma AG 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
DE60311662T2 (de) 2002-08-29 2007-10-25 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
US7470704B2 (en) 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
EP1537109B1 (en) * 2002-09-04 2007-04-18 ALTANA Pharma AG Novel benzonaphthyridines
IS7839A (is) * 2002-11-22 2004-05-23 Merck Frosst Canada Ltd. 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
AU2005212857B2 (en) * 2004-02-18 2011-04-28 Takeda Gmbh Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
ES2427256T3 (es) 2004-03-03 2013-10-30 Takeda Gmbh Nuevas hidroxi-6-heteroaril-fenantridinas y su uso como agentes inhibidores de la PDE4
WO2005084104A2 (en) * 2004-03-09 2005-09-15 Altana Pharma Ag Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
JP2007527900A (ja) * 2004-03-10 2007-10-04 アルタナ ファルマ アクチエンゲゼルシャフト チオ含有の新規のヒドロキシ−6−フェニルフェナントリジン及びpde4インヒビターとしてのそれらの使用
KR20060130697A (ko) * 2004-03-10 2006-12-19 알타나 파마 아게 신규한 아미도-치환 히드록시-6-페닐페난트리딘 및 pde4억제제로서의 이의 용도
EP1725532A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
CA2559200A1 (en) * 2004-03-17 2005-09-29 Altana Pharma Ag Novel n- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors
CA2579000C (en) * 2004-09-08 2013-02-05 Altana Pharma Ag Novel 3-thia-10-aza-phenanthrene derivatives
ES2365926T3 (es) 2004-09-08 2011-10-13 Nycomed Gmbh 3-oxa-10-aza-fenantrenos como inhibidores de pde4 o pde3/4.
NZ560268A (en) 2005-03-02 2010-12-24 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
PT937074E (pt) 1996-11-11 2003-07-31 Altana Pharma Ag Benzonaftiridinas como terapeutica bronquica

Also Published As

Publication number Publication date
DK1075477T3 (da) 2003-06-30
JP2002513793A (ja) 2002-05-14
ATE234301T1 (de) 2003-03-15
DE59904535D1 (de) 2003-04-17
CA2330738A1 (en) 1999-11-11
EP1075477B1 (de) 2003-03-12
EP1075477A1 (de) 2001-02-14
WO1999057118A1 (de) 1999-11-11
ES2195571T3 (es) 2003-12-01
US6306869B1 (en) 2001-10-23
AU3928999A (en) 1999-11-23
PT1075477E (pt) 2003-07-31

Similar Documents

Publication Publication Date Title
SI1075477T1 (sl) Novi benzonaftiridin-N-oksidi
CA2297911A1 (en) Substituted 6-phenylphenanthridines
PL334561A1 (en) Novel phtalysinones
SI1070056T1 (sl) Ftalazinonski PDE III/IV inhibitorji
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
TR200400702T4 (tr) AMP özgü fosfodiesteraz inhibtörleri olarak 3-tiazol-4-il-pirolidin türevleri.
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
WO2003087088A3 (en) (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
PL338339A1 (en) Novel derivatives of tetrazole
DK1109810T3 (da) Benzonaphthydin-N-oxider med PDE3- og PDE4-inhiberende aktivitet
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
PT1147103E (pt) Fenantridina-n-oxidos com actividade inibitoria de pde-iv
PL341239A1 (en) Dihydrobenzofuranes
SI1147087T1 (sl) Fenantridni-N-oksidi s PDE-IV inhibicijsko aktivnostjo
MXPA02012263A (es) 5-aminoalquil-pirazol[4,3-d]pirimidinas.
SI1377574T1 (sl)
MXPA02012260A (es) 2-aminoalquil-tieno[2,3-d]pirimidinas.